Patent ID: 7867991

Claim:
A method for reducing low density lipoprotein-(LDL)-cholesterol and increasing high density lipoprotein-(HDL)-cholesterol, the method consisting of: administering an agent, wherein the agent consists of a therapeutically effective amount of a compound sufficient to (a) at least partially activate peroxisome proliferator activated receptor-gamma (PPAR-γ), and (b) at least partially inhibit, antagonize, or block an activity of angiotensin II type 1 receptors to a human in need thereof with an elevated level of LDL-cholesterol and a reduced level of HDL-cholesterol, wherein the compound is selected from the group consisting of telmisartan and irbesartan, wherein said therapeutically effective amount of the compound reduces the level of LDL-cholesterol and increases the level of HDL-cholesterol in the human.